Patent · US Active

1- [1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives

US10125097B2 · kind B2 · utility

1Cited by

2References

18Claims

0Family size

Assignees

UNIVERSITAT DE BARCELONA · ES
FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) · ES
IPROTEOS S.L. · ES

Inventors

Ernest Giralt Lledó · Barcelona, ES
Teresa Tarragó Clua · Barcelona, ES
Roger Prades Cosano · Barcelona, ES
Soledad Royo Gracia · Barcelona, ES

Key dates

Filing date	Nov 11, 2013
Grant date	Nov 13, 2018
Priority date	—
Expiry date	Jan 16, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives having pharmacological activity to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of a cognitive disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.